A novel vascular graft, based on our platform STAR biomaterial, to address the critical need for improved means of dialysis access in kidney failure patients.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, US
  • Currency USD
  • Founded March 2007
  • Employees 7
  • Incorporation Type C-corp
  • Website healionics.com

Company Summary

Healionics is addressing the critical need for safer, more reliable means of dialysis access in kidney failure patients. Our STARgraft synthetic blood vessel is designed to resist the problems of occlusion and infection suffered by current devices. We also have an exciting product pipeline based on our platform STAR biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring & infection.


  • 30 years experience in the medical device industry as an entrepreneur, venture capitalist, and CEO. Cofounded several device companies, three of which (Novacept, Cohesion Technologies, Pulmonx) have reached exits worth a combined >$2B. Led the regional office for $400M venture capital firm vSpring (now Signal Peak). CEO of two early-stage device companies. Stanford MBA, M.I.T. MS, U.S. Naval Academy BS.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free